Conan MacDougall
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 20
- Co-authors
- Ron E. PolkJohn R. PerfectJohn RexMelissa D. JohnsonLuis Ostrosky‐ZeichnerRonald E. PolkKatherine GruenbergAmy Pakyz
- Journals
- Open Forum Infectious Diseases (7 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)American Journal of Pharmaceutical Education (5 papers)Clinical Infectious Diseases (3 papers)Current Infectious Disease Reports (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Conan MacDougall
53 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Applied Microbiology and Biotechnology 881
- Molecular Medicine 378
- Clinical Biochemistry 375
- Geriatrics and Gerontology 204
- Infectious Diseases 724
Countries citing papers authored by Conan MacDougall
This map shows the geographic impact of Conan MacDougall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conan MacDougall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conan MacDougall more than expected).
Fields of papers citing papers by Conan MacDougall
This network shows the impact of papers produced by Conan MacDougall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conan MacDougall. The network helps show where Conan MacDougall may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Conan MacDougall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 5 | |
| 8 | 2018 | 29 | |
| 9 | 2018 | 25 | |
| 10 | 2018 | 85 | |
| 11 | 2017 | 13 | |
| 12 | 2015 | 55 | |
| 13 | 2010 | 3 | |
| 14 | 2009 | 62 | |
| 15 | 2009 | 39 | |
| 16 | 2008 | 55 | |
| 17 | 2008 | 140 | |
| 18 | 2006 | 78 | |
| 19 | 2004 | 80 | |
| 20 | 2004 | 27 |
About Conan MacDougall
Conan MacDougall is a scholar working on Applied Microbiology and Biotechnology, Family Practice, Molecular Medicine, Clinical Biochemistry and Geriatrics and Gerontology, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (20 papers), Bacterial Identification and Susceptibility Testing (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (11 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Pneumonia and Respiratory Infections (6 papers) and Innovations in Medical Education (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (881 citations), Molecular Medicine (378 citations), Clinical Biochemistry (375 citations), Geriatrics and Gerontology (204 citations) and Infectious Diseases (724 citations). Conan MacDougall has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Ron E. Polk, John R. Perfect, John Rex, Melissa D. Johnson, Luis Ostrosky‐Zeichner, Ronald E. Polk, Katherine Gruenberg, Amy Pakyz, Michael Oinonen and Michael B. Edmond. Their work appears in journals such as Open Forum Infectious Diseases, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, American Journal of Pharmaceutical Education, Clinical Infectious Diseases and Current Infectious Disease Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.